Navigation Links
SoftLight Development, Inc. Ranks No. 643 on the 2009 Inc. 5000 with Three-Year Sales Growth of 429.7%
Date:9/11/2009

IRVING, Texas, Sept. 11 /PRNewswire/ -- Inc. magazine has ranked SoftLight Development, Inc. (SLD) NO. 643 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy--America's independent-minded entrepreneurs. Consumer electronics maker Vizio, Internet giant GoDaddy, rental car service Zipcar, and beverage maker Honest Tea are among the prominent brands featured on this year's list.

"Savvy trend spotters and those who invest in private companies know that the Inc. 5000 is the best place to find out about young companies that are achieving success through a wide variety of unprecedented business models, as well as older private companies that are still expanding at an impressive rate," said Inc. 5000 project manager Jim Melloan. "That's why our list is so eagerly anticipated every year."

SLD serves clinical organizations, including the offices of general practitioners, as well as emergency rooms, neonatal, prenatal, orthopedic, cardiovascular and other specialized practices. It delivers consultation, software design and systems solutions for imaging, document management, practice management, as well as healthcare hardware and software. SLD has developed customer healthcare software and systems for more than 15 years.

The 2009 Inc. 5000, unveiled on Inc.com, serves as a unique report card on the U.S. economy. Despite the ongoing recession, aggregate revenue among the companies on the list actually increased to $214 billion, up $29 billion from last year, with a median three-year growth rate of 126 percent. The Inc. 5000 are responsible for creating more than 1 million jobs since their founding, making the list perhaps the best example of the impact private, fast-growing companies can have on the economy. Complete results of the I
'/>"/>

SOURCE SoftLight Development, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
2. Crdentia Appoints Debbie Griffith to Director of Business Development, Reporting Directly to CEO
3. Amalgam fillings dont affect childrens brain development, says study in ADA Journal
4. Amalgam Fillings Dont Affect Childrens Brain Development, Says Study in ADA Journal
5. On The Go Healthcare, Inc. Issued New Trading Symbol and Completes Reverse Split and Name Change to Metro One Development, Inc.
6. Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position
7. Scientists identify interacting proteins key to melanoma development, treatment
8. Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms
9. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
10. Tiny molecule helps control blood-vessel development, UT Southwestern researchers find
11. ISCAR, world-wide conference on role of culture in human development, convenes at UCSD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... (July 30, 2014) The phrase "we caught it early" ... in the midst of a cancer diagnosis. Combating cancer ... to a certain part of the body, gives patients ... breast, skin, colon, prostate and other forms of cancer ... health care providers recommend cancer screenings as a precautionary ...
(Date:7/30/2014)... Orange, NJ. July 30, 2014. A new network of ... NIH Stroke Trials Network (NIH StrokeNet) is working ... the U.S. Despite advances of the last two ... year, stroke causes death or disability for 795,000 Americans. ... aging of the population. , To accelerate the ...
(Date:7/30/2014)... 30, 2014 The Technology Association of ... of TAG (B&TA), today issued its final call for ... , Interested companies have until August 29th 2014 to ... will be selected by the Excalibur Judging Committee. Companies ... with the judges for interviewing process. , The ...
(Date:7/30/2014)... July 30, 2014 Over 630 doctors ... Surgical Technique®, the revolutionary minimally invasive treatment for gum ... by many of his peers to be the “father ... at a recent Chao Pinhole Surgical Technique® training course ... Shanelec is the recipient of the American Academy of ...
(Date:7/30/2014)... July 30, 2014 As the controversy ... in gynecological surgeries continues to grow, Bernstein Liebhard LLP ... those calling for a ban on uterine morcellation. According ... was diagnosed with leiomyosarcoma following a hysterectomy that involved ... of her diagnosis, the aggressive cancer had progressed to ...
Breaking Medicine News(10 mins):Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 2Health News:Last Call for TAG 2014 Excalibur Awards Nominations and Applications 3Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4
... a greater risk of suffering from overweight and obesity. This ... children examined on starting school. Elisabeth Weber and her coauthors ... rzteblatt International ( Dtsch Arztbl Int 2008; 105 ... weight, and height of the children, but also their mother ...
... they behave like engineering parts is the focus of research ... 8 million grant from the Engineering and Physical Sciences Research ... synthetic biology. This is a field in which engineers work ... These parts could be used to build biological devices that ...
... want it must give up aggressive treatments, researchers say ... with life-threatening illnesses would seek hospice care if Medicare ... give up aggressive treatment of their ailments, a new ... but the issue was one of money, not race, ...
... is now open. The auction will run from December 18, ... Nick Foundation, Inc, a charity dedicated to male breast cancer awareness ... timeshares to donated items guaranteed to delight and surprise. Tell your ... ...
... Ride Home Program on New Year,s Eve , ... Terre Haute, Ind. (PRWEB) December 22, ... Yellow Cab of Terre Haute to provide free transportation to those who can,t ... Eve. The Safe and Sober Free Cab Ride Home program will be available ...
... -- A new study finds that hospice servicescare that ... aides, social workers and counselorshave restrictions that reduce usage ... Americans. The research, published in the February 1, 2009 ... the American Cancer Society, indicates that the eligibility criteria ...
Cached Medicine News:Health News:New center launched today to spearhead UK research in synthetic biology 2Health News:New center launched today to spearhead UK research in synthetic biology 3Health News:Rules Change Could Increase Hospice Use 2Health News:Holiday Online Auction - Dedicated to Awareness of Male Breast Cancer - Hosted by John W. Nick Foundation, Inc. at MaleBreastCancer.org 2Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 2Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 3Health News:Eligibility criteria contribute to racial disparities in hospice use 2
(Date:7/30/2014)... 2014 Research and Markets has ... Aseptic Packaging Industry Report 2014" report to their ... The Global and Chinese Aseptic Packaging Industry Report ... state of the global Aseptic Packaging industry with a ... a basic overview of the industry including definitions, classifications, ...
(Date:7/30/2014)... N.J. , July 30, 2014  InnoPharma, Inc. ... Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in ... agitation and disturbed behaviors in patients with schizophrenia or ... this generic injectable drug, InnoPharma has entered into an ... Sandoz Canada will make, use, sell, market and ...
(Date:7/30/2014)... and KISSING, Germany , July 30, ... a single use and computer-assisted ("robotic") colonoscopy system, today ... a worldwide recognized medical device executive, as a new ... Shamir is a highly respected global visionary in the ... served as President and Chief Executive Officer at Given ...
Breaking Medicine Technology:Global and Chinese Aseptic Packaging Industry Report 2014 2InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3
... Isis Pharmaceuticals,Inc. (Nasdaq: ISIS ) announced ... from a randomized Phase 2 clinical trial of,OGX-011 ... arm"),compared to docetaxel and prednisone alone ("the control ... cancer. The current 10.6,month median overall survival ...
... DIEGO, Dec. 3 Vical Incorporated,(Nasdaq: VICL ... with EIP,Eczacibasi Ilac Pazarlama A.S. (EIP) for sales and ... and the Turkish,Republic of Northern Cyprus. EIP has agreed ... to pay Vical upfront and milestone payments,plus a specified ...
Cached Medicine Technology:Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5
... Plus Instrument for applications ... ,The VERSASTEP™ Plus ... working length is a ... utilizing radial dilation. It ...
... system device is comprised of the following ... access port are also packaged in the ... cone with 12 mm Step™ cannula assembly ... 12 mm locking cone with 10/12 mm ...
... The Step™ and Mini Step™ device components are ... Step™ Single Use System is supplied sterile in ... packaged in various configurations and combinations. They are ... Access needle and the Step™ radially Expandable Sleeve. ...
... The Premium One-Step™ single-use system device is ... ,The device components for creating each access ... configurations: , Step™ insufflation and access ... packaged separately. , Step™ radially expandable sleeve, ...
Medicine Products: